Recovery Trials

  • June 28, 2020
  • Posted by: admin1
  • Category: DPN Topics
No Comments
Print Friendly, PDF & Email

Subject: Science and tech

Concept:

  • As part of the RECOVERY trial, a range of potential treatments is being tested in patients being admitted to the UK National Health Service (NHS) hospitals that are positive for COVID-19.
  • Sponsored by Oxford University in England, the trial is assessing the effectiveness of different potential COVID-19 treatments on their ability to reduce all-cause (overall) mortality within 28 days.
  • RECOVERY Trial is testing a handful of drugs in consenting patients:
  • Lopinavir-Ritonavir (commonly used to treat HIV)
  • Low-dose Dexamethasone (a corticosteroid medicine used to treat inflammation)
  • Hydroxychloroquine (an anti-malarial drug used to prevent and treat malaria in areas where malaria is sensitive to chloroquine)
  • Azithromycin (a commonly-used antibiotic)
  • Tocilizumab (an anti-inflammatory treatment given by injection)
  • Convalescent plasma (collected from donors who have recovered from COVID-19 and contains antibodies against the SARS-CoV-2 virus).
Recovery Trials Science and tech